journal article·2020-05-20Open access

Evaluation of Experimental Multi-Particulate Polymer-Coated Drug Delivery Systems with Meloxicam

Mircea Hîrjău, Dalia Simona Miron, Valentina Anuța, Dumitru Lupuliasa, Mihaela Violeta Ghica, Viorel Jinga, Cristina-Elena Dinu-Pîrvu

Coatings· Volume 10· Issue 5

Abstract

The objectives of this study are the development and evaluation of modified release multi-particulate drug delivery systems containing a BCS class II drug (meloxicam), formulated as polymer-coated pellets. Inert seeds containing microcrystalline cellulose, lactose monohydrate, and polyvinylpyrrolidone were prepared by extrusion-spheronization. The obtained cores were loaded with meloxicam using the drug layering technique, by spray coating in a fluidized bed with a liquid dispersion of the drug. The resulting drug pellets were film-coated with various polymers (Acryl-EZE® 93O, Eudragit® RS 30-D as well as experimental composite obtained by adding Methocel™ E5 Premium LV as pore forming agent to the extended release polymer Eudragit® RS 30-D). All experimental systems were evaluated by scanning electron microscopy and in vitro release testing, in an attempt to investigate the characteristics of the film coatings and their influence on drug release from the multi-particulate systems. The in vitro release study was performed in two stages, using two media with pH values corresponding to the gastric and intestinal environment (HCl 0.1N, pH = 1.2 for the first two hours of the test and phosphate buffer 50 mM, pH 6.8 for the next 4 h). The in vitro release data have highlighted the impact of the formulation factors on the drug release.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Drug Solubulity and Delivery Systems · Advanced Drug Delivery Systems · Microencapsulation and Drying Processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania

Department of Pharmaceutical Physics and Informatics, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania

Department of Physical and Colloidal Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania

Department of Clinical Sciences no.3, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania

Funding

Universitatea de Medicină şi Farmacie "Carol Davila" Bucureşti

References (52)

Show source-provided references
1. Ghebre-Selassie, I., and Martin, C. (2003). Pharmaceutical Extrusion Technology, Taylor & Francis.10.1201/9780203911532 ↗
2. Partheniadis, I., Gkogkou, P., Kantiranis, N., and Nikolakakis, I. (2019). Modulation of the Release of a Non-Interacting Low Solubility Drug from Chitosan Pellets Using Different Pellet Size, Composition and Numerical Optimization. Pharmaceutics, 11.10.3390/pharmaceutics11040175 ↗
3. Preparation and Characterization of Pellets Containing a Non-steroidal Antiinflamatory Drug, Coated with an Enteric Polymer
4. The Study of Piroxicam Dissolution from Eudragit RS-Coated Pellets
5. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets10.1016/j.ijpharm.2006.05.011 ↗
6. Tablets of multi-unit pellet system for controlled drug delivery10.1016/j.jconrel.2017.07.043 ↗
7. Preparation and in vitro Characterization of Pellets Containing Felodipine Solid Dispersions
8. Polymer–drug interactions and wetting of solid dispersions10.1016/j.ejps.2009.11.005 ↗
9. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine10.1016/j.ejpb.2008.05.023 ↗
10. Study of the preparation of a multiparticulate drug delivery system with a layering technique10.1016/j.powtec.2010.09.006 ↗
11. Novel compaction techniques with pellet-containing granules10.1016/j.ejpb.2010.04.011 ↗
12. Theismann, E.M., Keppler, J.K., Owen, M., Schwarz, K., and Schlindwein, W. (2019). Modelling the Effect of Process Parameters on the Wet Extrusion and Spheronisation of High-Loaded Nicotinamide Pellets Using a Quality by Design Approach. Pharmaceutics, 11.10.3390/pharmaceutics11040154 ↗
13. Tramadol SR formulations: Pharmacokinetic comparison of a multiple-units dose (capsule) versus a single-unit dose (tablet)
14. Extrusion–spheronization a promising pelletization technique: Indepth review10.1016/j.ajps.2016.08.001 ↗
15. Pelletization process and techniques
16. Optimization of pellets manufacturing process using rough set theory10.1016/j.ejps.2018.08.027 ↗
17. Sarkar, S., Liew, C.V., Soh, J.L.P., Heng, P.W.S., and Wong, T.W. (2017). Microcrystalline cellulose: An overview. Functional Polymeric Composites, Apple Academic Press.10.1201/9781315207452-3 ↗
18. Swarbrick, J., and Boylan, J.C. (2002). Extrusion and extruders. Encyclopedia of Pharmaceutical Technology, Marcel Dekker Inc.
19. Physico-mechanical characterization of the extrusion-spheronization process. Part II: Rheological determinants for successful extrusion and spheronization10.1023/A:1016237509740 ↗
20. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronization10.1016/0378-5173(94)00246-2 ↗
21. Al-Hashimi, N., Begg, N., Alany, R.G., Hassanin, H., and Elshaer, A. (2018). Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles. Pharmaceutics, 10.10.3390/pharmaceutics10040176 ↗
22. Wan, D., Zhao, M., Zhang, J., and Luan, L. (2019). Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer. Pharmaceutics, 11.10.3390/pharmaceutics11060260 ↗
23. Lin, H., Zhang, Z., Markl, D., Zeitler, J.A., and Shen, Y. (2018). A Review of the Applications of OCT for Analysing Pharmaceutical Film Coatings. Appl. Sci., 8.10.3390/app8122700 ↗
24. An update on pharmaceutical film coating for drug delivery10.1517/17425247.2013.763792 ↗
25. Yang, Q., Yuan, F., Xu, L., Yan, Q., Yang, Y., Wu, D., Guo, F., and Yang, G. (2019). An update of moisture barrier coating for drug delivery. Pharmaceutics, 11.10.3390/pharmaceutics11090436 ↗
26. Clinical pharmacokinetics of meloxicam10.2165/00003088-199936020-00003 ↗
27. Meloxicam in the management of post-operative pain: Narrative review10.4103/joacp.JOACP_133_18 ↗
28. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability10.1023/A:1016212804288 ↗
29. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls10.1208/s12248-015-9743-7 ↗
30. Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 18810.1208/s12249-009-9316-0 ↗
31. Toward an understanding of NSAID-related adverse events: The contribution of longitudinal data10.3109/03009749609097225 ↗
32. Sustained release and enteric coated NSAIDs: Are they really GI safe?
33. Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (macaca fascicularis)
34. Polysaccharides based gastroretentive system to sustain piroxicam release: Development and in vivo prolonged anti-inflammatory effect10.1016/j.ijbiomac.2018.08.140 ↗
35. Image Analysis of the Shape of Granulated Powder Grains10.1002/jps.10572 ↗
36. Effect of different production variables on the physical properties of pellets prepared by extrusion-spheronization using a multivariate analysis
37. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion–spheronization10.1080/03639045.2017.1405975 ↗
38. (2020, March 10). ImageJ Website–NIH, Available online: https://imagej.nih.gov/ij/plugins/circularity.html.
39. Fahr, A. (2018). Test Methods for Powders and Granules. Voigt’s Pharmaceutical Technology, John Wiley & Sons Ltd.
40. Development of Enteric Coated Pantoprazole Tablets with an Aqueous Based Polymer
41. Development of salbutamol sulphate sustained release pellets using acrylic polymer and polyvinyl acetate polymer and evaluation of in vitro release kinetics10.3329/dujps.v9i2.7895 ↗
42. Controlled Porosity Solubility Modulated Osmotic Pump Tablets of Gliclazide10.1208/s12249-014-0246-0 ↗
43. Manda, A., Walker, R.B., and Khamanga, S.M.M. (2019). An Artificial Neural Network Approach to Predict the Effects of Formulation and Process Variables on Prednisone Release from a Multipartite System. Pharmaceutics, 11.10.3390/pharmaceutics11030109 ↗
44. USP 38-NF 33 (2015). The United States Pharmacopeia 38-the National Formulary 33, United States Pharmacopeial Convention Inc.
45. Mircioiu, C., Voicu, V., Anuta, V., Tudose, A., Celia, C., Paolino, D., Fresta, M., Sandulovici, R., and Mircioiu, I. (2019). Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics., 11.10.3390/pharmaceutics11030140 ↗
46. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles10.1208/s12248-010-9185-1 ↗
47. Research concerning the development of a biorelevant dissolution test for formulations containing norfloxacin. I. Modelling of in vitro release kinetics
48. ph induced swelling of pvp microgel particles–A first order phase transition?10.1016/j.jcis.2011.12.064 ↗
49. Charge controlled swelling of microgel particles10.1021/ma991520l ↗
50. Evaluating bioequivalence of meloxicam tablets: Is in-vitro dissolution test overdiscriminating?10.1111/jphp.12859 ↗
51. Dissolution test optimization for meloxicam in the tablet pharmaceutical form10.1590/S1984-82502009000100008 ↗
52. (2020, March 11). FDA—Dissolution Methods Database, Available online: https://www.accessdata.fda.gov/scripts/CDER/dissolution/dsp_SearchResults.cfm.